The Regulatory Pathway for Advanced Cell Therapy and Gene Therapy Products in Brazil: A Road to Be Built-Reference-Cited by-同舟云学术

The Regulatory Pathway for Advanced Cell Therapy and Gene Therapy Products in Brazil: A Road to Be Built

Published:2015 Issue: Volume: Page:213-219
ISSN:0065-2598
Container-title:Advances in Experimental Medicine and Biology
language:
Short-container-title:

Author:

de Freitas Daniel Roberto Coradi

Publisher

Springer International Publishing

Link

http://link.springer.com/content/pdf/10.1007/978-3-319-18618-4_12

Reference11 articles.

1. ANVISA. Board Resolution 153 June 14, 2004. http://portal.anvisa.gov.br/wps/wcm/connect/4bc8428047457945865fd63fbc4c6735/rdc_153.pdf?MOD=AJPERES . Accessed 29 Dec 2014

2. Institutional Technical Reports (2010) Ministry of Health. Cell therapy and stem cells research funding in Brazil. Rev Saude Publica 44(4):763–764

3. Brazil. Law 11,105 of March 25, 2005. http://www.planalto.gov.br/ccivil_03/_ato2004-2006/2005/lei/l11105.htm . Accessed 15 Dec 2014

4. Brazil. Decree 5,591 of November 22, 2005. http://www.planalto.gov.br/ccivil_03/_ato2004-2006/2005/Decreto/D5591.htm . Accessed 15 Dec 2014

5. ANVISA. Ordinance 498 of July 3, 2007. Official Gazette

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulatory Framework, Challenges, and Initial Strategic Planning for Advanced Therapy Products (PTAs) Development in Brazil;Therapeutic Innovation & Regulatory Science;2023-10-10

2. Global regulatory developments for clinical stem cell research: diversification and challenges to collaborations;Regenerative Medicine;2016-10

3. Cell therapy must be regulated as medicine;Experimental Hematology & Oncology;2015-12